Sy, Eduardo C.
HRN: 21-46-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2022
06/27/2022
IV
600mg
Q8H
Gangrenous Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes